Select Medical (SEM) to Release Quarterly Earnings on Thursday

Select Medical (NYSE:SEM) is anticipated to issue its Q2 2025 quarterly earnings data after the market closes on Thursday, July 31st. Analysts expect the company to announce earnings of $0.24 per share and revenue of $1.35 billion for the quarter.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.01). The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.40 billion. Select Medical had a net margin of 2.81% and a return on equity of 11.04%. The firm’s revenue for the quarter was down 24.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.75 earnings per share. On average, analysts expect Select Medical to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Select Medical Stock Down 0.8%

Shares of NYSE:SEM opened at $14.15 on Tuesday. The company has a market capitalization of $1.82 billion, a PE ratio of 10.56, a price-to-earnings-growth ratio of 0.76 and a beta of 1.32. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.16 and a quick ratio of 1.16. The business has a fifty day moving average price of $14.90 and a two-hundred day moving average price of $16.58. Select Medical has a 1 year low of $14.00 and a 1 year high of $40.98.

Select Medical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were paid a $0.0625 dividend. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $0.25 dividend on an annualized basis and a yield of 1.77%. Select Medical’s dividend payout ratio (DPR) is presently 18.66%.

Select Medical announced that its Board of Directors has approved a stock repurchase program on Thursday, May 1st that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the health services provider to reacquire up to 42.6% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board believes its stock is undervalued.

Analyst Ratings Changes

Several analysts have commented on the stock. Mizuho assumed coverage on shares of Select Medical in a research report on Wednesday, April 16th. They issued an “outperform” rating and a $25.00 price objective on the stock. Royal Bank Of Canada lowered their price objective on shares of Select Medical from $23.00 to $19.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 7th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $26.00.

Insider Buying and Selling

In related news, Director Parvinderjit S. Khanuja bought 21,000 shares of the business’s stock in a transaction on Monday, May 5th. The stock was acquired at an average price of $15.02 per share, for a total transaction of $315,420.00. Following the purchase, the director directly owned 65,089 shares in the company, valued at $977,636.78. This trade represents a 47.63% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 11.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Select Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of SEM. Dynamic Technology Lab Private Ltd bought a new position in shares of Select Medical in the 1st quarter worth $220,000. AQR Capital Management LLC increased its holdings in shares of Select Medical by 96.6% in the 1st quarter. AQR Capital Management LLC now owns 33,894 shares of the health services provider’s stock worth $566,000 after buying an additional 16,656 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Select Medical by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 64,400 shares of the health services provider’s stock worth $1,075,000 after buying an additional 2,809 shares during the last quarter. Royal Bank of Canada increased its holdings in shares of Select Medical by 8.5% in the 1st quarter. Royal Bank of Canada now owns 95,771 shares of the health services provider’s stock worth $1,599,000 after buying an additional 7,502 shares during the last quarter. Finally, Jane Street Group LLC bought a new position in shares of Select Medical in the 1st quarter worth $4,635,000. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.